Research output per year
Research output per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Matthijs Bossong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Effects of cannabidiol on symptoms in people at clinical high risk for psychosis
Bhattacharyya, S., Appiah-Kusi, E., Wilson, R., O'Neill, A., Brammer, M., Williams, S., Perez, J., Bossong, M. G. & McGuire, P., Oct 2024, In: World Psychiatry. 23, 3, p. 451-452 2 p.Research output: Contribution to journal › Letter › peer-review
Open Access2 Citations (Scopus) -
Transcriptional and neurochemical signatures of cerebral blood flow alterations in schizophrenia and the clinical high-risk state for psychosis
Knight, S., Abbasova, L., Zeighami, Y., Hansen, J. Y., Martins, D., Zelaya, F., Dipasquale, O., Liu, T., Shin, D., Bossong, M., Azis, M., Antoniades, M., Howes, O., Bonoldi, I., Egerton, A., Allen, P., O'Daly, O., McGuire, P. & Modinos, G., 14 Mar 2024.Research output: Working paper/Preprint › Preprint
Open Access -
Increased hippocampal blood flow in people at clinical high risk for psychosis and effects of cannabidiol
Davies, C., Bossong, M., Martins, D., Wilson, R., Appiah-Kusi, E., Blest Hopley, G., Zelaya, F., Allen, P., Brammer, M., Perez, J., McGuire, P. & Bhattacharyya, S., 17 Oct 2023, (E-pub ahead of print) In: Psychological Medicine.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)55 Downloads (Pure) -
The relationship between grey matter volume and clinical and functional outcomes in people at clinical high risk for psychosis
EU-GEI High Risk Study*, 10 Jun 2022, (Accepted/In press) In: Schizophrenia Bulletin Open.Research output: Contribution to journal › Article › peer-review
-
Adverse clinical outcomes in people at clinical high-risk for psychosis related to altered interactions between hippocampal activity and glutamatergic function
Allen, P., Hird, E. J., Orlov, N., Modinos, G., Bossong, M., Antoniades, M., Sampson, C., Azis, M., Howes, O., Stone, J., Perez, J., Broome, M., Grace, A. A. & McGuire, P., Dec 2021, In: Translational psychiatry. 11, 1, 579.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus)
Projects
- 2 Finished
-
Evaluation of cannabidiol as a treatment for the early phase of psychosis
McGuire, P. (Primary Investigator), DO NOT USE, P. (Co-Investigator), Barker, G. (Co-Investigator), Bhattacharyya, S. (Co-Investigator), Bossong, M. (Co-Investigator) & Morrison, P. (Co-Investigator)
1/04/2013 → 30/09/2014
Project: Research
-
Towards prevention of schizophrenia: the potential of a cannabidiol as a novel antipsychotic agent
Bossong, M. (Primary Investigator) & McGuire, P. (Co-Investigator)
Netherlands Organisation for Scientific Research
1/05/2012 → 30/04/2014
Project: Research